1.
Ali AJ, Chaudhary T, Abdul Razzaq, et al. Cardiovascular Benefits and Pharmacological Mechanisms of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Narrative Review. IJBR. 2026;4(2):47-57. doi:10.70749/ijbr.v4i2.2909